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Background: Percutaneous coronary intervention (PCI) is increasingly utilized for
treatment of coronary disease involving the unprotected left main stem (ULMS).
However, no studies to date have examined the outcomes of such interventions
when complicated by coronary perforation (CP).
Methods: Using the British Cardiovascular Intervention society (BCIS) database, data
were analyzed on all ULMS-PCI procedures complicated by CP in England and Wales
between 2007 and 2014. Multivariate logistic regressions were used to identify pre-
dictors of ULMS CP and to evaluate the association between this complication and
outcomes.
Results: During 10,373 ULMS-PCI procedures, CP occurred more frequently than in
non-ULMS-PCI (0.9 vs. 0.4%, p < .001) with a stable annual incidence. Covariates
associated with CP included number of stents used, female gender, use of rotational
atherectomy and chronic total occlusion (CTO) intervention. Adjusted odds of
adverse outcomes for ULMS-PCI complicated by CP were higher for peri-procedural
complications including cardiogenic shock, tamponade, side-branch loss, DC cardio-
version, in-hospital major bleeding, transfusion requirement, and peri-procedural
myocardial infarction. There were also significantly increased odds for in-hospital
major adverse cardiac events (MACCE, OR 8.961, 95% CI [4.902–16.383]) and
30-day mortality (OR 5.301, 95% CI [2.741–10.251]).
Conclusions: CP is an infrequent event during ULMS-PCI and is predicted by female
gender, rotational atherectomy, CTO interventions or number of stents used. CP was
associated with significantly higher odds of mortality and morbidity, but at rates simi-
lar to previously published all-comer PCI complicated by CP.
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1 | INTRODUCTION
Left main stem (LMS) coronary artery stenosis is associated with sig-
nificant morbidity and mortality and has traditionally been treated by
coronary artery bypass grafting (CABG).1 Recently, however, there
has been an increasing amount of evidence emerging in favor of utiliz-
ing percutaneous coronary intervention (PCI) in patients with unpro-
tected LMS disease unprotected left main stem (ULMS-PCI).2 This has
been the result of advancements in the PCI field, which saw the rise
of using drug-eluting stents, the precision of intravascular imaging and
the utility of risk stratification tools to refine patient selection.1
Coronary perforation (CP) is a rare but serious complication of
PCI which has been shown to have an incidence of ~0.4% of all proce-
dures.3 The rate of perforations complicating ULMS interventions has
been reported to be in the region of 1.2% from single-center experi-
ence.4 However, the literature surrounding ULMS perforation, its pre-
dictors and likely outcomes are very limited.
Studies examining predictors of perforation in all-comer PCI have
suggested that increasing age, female gender, chronic total occlusion
(CTO) intervention, number and length of stents used, and rotational
atherectomy are associated with an increased rate with perforation.3,5
Overall, perforation was observed to lead to higher rates of 30-day
mortality.3,5 Despite this, it is unclear whether these predictors and
outcomes apply to ULMS-PCI complicated by perforation.
Therefore, the primary objective of this study was first to define
the incidence, temporal trends, predictors, and outcomes of perfora-
tion associated with ULMS-PCI through analysis of the British Cardio-
vascular Society (BCIS) national PCI database.
2 | METHODS
2.1 | Study design, setting, and participants
We retrospectively analyzed national data from all patients undergo-
ing ULMS-PCI in England and Wales between January 2007 and
December 2014. During the study period, a total of 10,373 patients
underwent ULMS-PCI. Patients were excluded if CP status was not
recorded. The study was approved by review board of the National
Institute of Clinical Outcomes Research and by the Healthcare Quality
Improvement Partnership (HQIP).
2.2 | Setting, data source, and study size
Data on PCI practice in the United Kingdom were obtained from the
BCIS data set that records this information prospectively and pub-
lishes this information in the public domain as part of the national
transparency agenda.6
The data collection process is overseen by The National Institute
of Cardiovascular Outcomes Research (NICOR) (http://www.ucl.ac.
uk/nicor/) with high levels of case ascertainment. The BCIS-NICOR
database contains 121 clinical, procedural and outcomes variables,
and in 2014, 98.6% of all PCI procedures performed in the National
Health Service (NHS) hospitals in England and Wales (www.bcis.org.
uk/) were recorded on the database with approximately 100,000 new
records currently added each year. The accuracy and quality of the
BCIS data set has previously been ascertained.7
Entry of all PCI procedures by UK interventional operators is
mandated as part of professional revalidation. The participants of the
database are tracked by the Medical Research Information Services
for subsequent mortality using the patients' National Health Service
(NHS) number (a unique identifier for any person registered within
the NHS in England and Wales). Although the BCIS data set is UK
wide, the participants of the database are tracked by linkage with life
status information held by the Office of National Statistics (ONS)
using each patient's unique NHS number, and therefore only patients
from England and Wales have mortality data available.
2.3 | Study definitions
We analyzed all recorded ULMS-PCI procedures that were undertaken
in England and Wales between January 1, 2007 and December
31, 2014. CP was defined as in the BCIS guidance document as evi-
dence of extravasation of dye or blood from any coronary artery during
or following an interventional coronary procedure. Other study defini-
tions were used as in the BCIS-NICOR database. Specifically, prep-
rocedural renal failure is defined as any one of the following: creatinine
>200 μmol/L, renal transplant history, or dialysis. Pre- or post-PCI dis-
ease severity was defined as a stenosis ≥50% in the case of the left
main artery. Intravascular imaging was a combination of intravascular
ultrasound and optical coherence tomography. An access site complica-
tion was defined as either a false aneurysm, hemorrhage (without
hematoma), hemorrhage with delayed hospital-discharge, retroperito-
neal hematoma, arterial dissection, or any access site complication
requiring surgical repair. The clinical outcomes examined were in-
hospital mortality, in-hospital MACCE (defined as a combination death,
peri-procedural stroke, or peri-procedural myocardial infarction after
PCI), in-hospital major bleeding (defined as either gastrointestinal bleed,
intra-cerebral bleed, retroperitoneal hematoma, blood or platelet trans-
fusion, access site hemorrhage, or an arterial access site complication
requiring surgery), in-hospital reinfarction, in-hospital emergency car-
diac surgery, tamponade, and 12-month mortality.
2.4 | Data analyses
The study flow is illustrated in Figure S1. Procedures with a protected
LMS or missing LMS protection status were excluded as were proce-
dures where the perforation status was blank. Statistical analysis was
performed using the R coding environment (Open Source, version
3.5.1). Multiple imputations were carried out using the mice package
to reduce the potential bias from missing data, assuming missing at
random mechanisms. We used chained equations to impute the data
for all variables with missing information and generated 10 data sets
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to be used in the analyses. We examined the baseline and procedural
characteristics of participants by CP status. We explored crude base-
line comorbidities using a Chi-squared test for categorical variables
and the Wilcoxon-Mann–Whitney test for continuous variables.
A multiple logistic regression model was developed to identify vari-
ables associated with CP. The potential predictor variables in the model
included age, body mass index (BMI), sex, smoking, hypertension, previ-
ous stroke, peripheral vascular disease, renal disease, previous MI,
EF < 30%, previous PCI, diabetes, number of vessels diseased at base-
line, CTO attempted, number of stents used, STEMI, Q wave on ECG,
GPIIBIIIA inhibitor use, clopidogrel, prasugrel, ticagrelor, bivalirudin, radial
access, dual access, largest balloon/stent, longest balloon/stent, vessels/
lesions attempted, in-stent restenosis attempted, thrombectomy, rota-
tional atherectomy, imaging, operator status, penetration catheter, laser
atherectomy, and micro-catheter use.
To examine the influence of perforation on ULMS-PCI outcomes,
we built on and included the previously described baseline model to
investigate the independent odds of shock, tamponade, cardioversion,
dissection, side branch loss, slow flow phenomenon, gastrointestinal
bleeding, transfusion, in-hospital major bleeding, peri-procedural myo-
cardial infarction, arterial complication, acute kidney injury, in-hospital
MACCE, in-hospital, 30 day, and 12 month death.
3 | RESULTS
3.1 | Incidence of CP and baseline demographics
during ULMS-PCI by perforation status
Crude numbers of ULMS-PCI increased significantly during the study
period, as did ULMS-PCI activity of as a percentage of the total PCI
(increasing from 2.0 to 4.1%, p < .001 for trend, Figure 1a/b). During
the study period, a total of 10,373 patients underwent ULMS-PCI for
any indication, of whom 96 (0.9%) experienced CP. The frequency of
ULMS perforation was higher than in non-ULMS-PCI (0.9 vs. 0.4%,
p < .001). The total number of ULMS-PCI increased from 583 in 2007
to 2,030 in 2014 with a stable rate of perforation (Figure 1c). The
baseline characteristics of ULMS-PCI patients with and without CP
are presented in Table 1. CP was associated with increasing patient
age, female sex, hypertension, and number of diseased vessels at
baseline (p < .05, unadjusted).
3.2 | Procedural variables during ULMS-PCI by
perforation status
The procedural variables for patients with and without CP by vessel
type are presented in Table S1. ULMS-PCI cases with perforation
were associated with more vessels and lesions attempted, CTO inter-
vention, thrombus aspiration, rotational atherectomy, micro-catheter
use, and the use of more stents during the procedure (p < .05,
unadjusted).
3.3 | Predictors of CP during ULMS-PCI in England
and Wales 2007–2014
Using multivariate analyses, only a limited number of covariates were
found to be associated with CP during ULMS-PCI. After adjusting for
baseline comorbidities, the only patient-related factor significantly asso-
ciated with an increased incidence of perforation was female gender
(odds ratio [OR] 1.887, 95% confidence intervals [CIs] [1.134–3.141]).
F IGURE 1 Trends in LMS-PCI performed in England and Wales 2007–2014. (a) Crude numbers of LMS (dark gray bars) and nonLMS-PCI
(light gray bars); (b) percentage of total PCI performed represented by LMS-PCI (p < .001 for trend); (c) percentage of ULMS-PCI complicated by
perforations relative to all ULMS-PCI (p = .178, not significant, for trend)
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Procedural variables significantly associated with an adjusted increased
risk of perforation were number of stents used (OR 1.390, 95% CI
[1.166–1.656]), number of CTO attempted (OR 2.036, 95% CI
[1.350–3.072]) and use of rotational atherectomy (OR 2.494, 95% CI
[1.305–4.765]). The full model with all covariates can be seen in
Table S2.
3.4 | Clinical outcomes of ULMS-PCI by
perforation status
The unadjusted incidence of procedural complications associated with
CP in ULMS-PCI is shown in Table S3. Complications crudely associ-
ated with CP were shock, tamponade, cardioversion, major side
branch loss, more residual disease, transfusion, in-hospital major
bleeding, peri-procedural MI, and in-hospital MACCE (p < .05).
Unadjusted mortality rates at 30 days, at 12 months and in-hospital
were higher in cases where perforation occurred.
Multivariate logistic modeling was used to adjust outcomes for
baseline comorbidities (Table 2). This showed that perforation compli-
cating ULMS-PCI inferred significantly higher odds of in-hospital
major adverse cardiac events (MACCE, OR 8.961, 95% CI
[4.902–16.383]), 30-day mortality (OR 5.301, 95% CI
[2.741–10.251]), and 12-month mortality (OR 2.412, 95% CI
[1.325–4.390]). There were also higher odds of peri-procedural com-
plications, such as shock, tamponade, DCCV, side-branch loss, in-
hospital major bleed, transfusion requirement, and peri-procedural
MI (p < .05).
TABLE 1 Baseline participant characteristics by coronary perforation status in patients undergoing LMS-PCI in England and Wales
2007–2014
Variables Not perforated (n = 10,277) Perforated (n = 96) p value
Age (years), ±SD 70.2 ± 11.9 73.8 ± 10.4 .004
Female, no. (%) 2,952 (28.8) 38 (39.6) .027
Smoker, no. (%) 5,696 (61.2) 50 (56.8) .466
BMI (kg/m2), ±SD 28.2 ± 12.8 28 ± 4.6 .480
Hypertension, no. (%) 6,141 (62.8) 65 (73.9) .043
Diabetes, no. (%) 2,418 (24) 23 (25.6) .826
Previous MI, no. (%) 3,718 (37.6) 36 (39.6) .783
Previous stroke, no. (%) 733 (7.5) 11 (12.5) .118
Peripheral vascular disease, no. (%) 1,080 (11) 13 (14.8) .340
Q wave on ECG, no. (%) 1,232 (12.8) 5 (5.5) .054
Renal disease, no. (%) 619 (6.3) 6 (6.7) 1.000
Creatinine (±mol/L), ±SD 107.8 ± 75.4 99.4 ± 38.8 .859
Previous PCI, no. (%) 2,725 (27) 21 (23.1) .471
LVEF <30%, no. (%) 813 (12.6) 8 (10.7) .744
Cardiogenic shock, no. (%) 0.0 (0.0) 0.0 (0.0) —
ST elevation presentation, no. (%) 1,010 (9.8) 6 (6.2) .307
Clopidogrel 7,637 (89.2) 74 (85.1) .288
Prasugrel 314 (3.7) 2 (2.3) .686
Ticagrelor 615 (7.2) 10 (11.5) .184
Warfarin, no. (%) 134 (1.4) 0.0 (0.0) —
No. of vessels diseased at baseline, ±SD 2.0 ± 1.0 2.3 ± 1.0 .035
Number of procedures per year (%)
2007 578 (99.1%) 5 (0.9%) 1.000
2008 656 (98.9%) 7 (1.1%) .884
2009 948 (99.7%) 3 (0.3%) .057
2010 994 (98.6%) 14 (1.4%) .152
2011 1,326 (99.4%) 8 (0.6%) .239
2012 1,578 (98.9%) 18 (1.1%) .446
2013 1,667 (99.2%) 14 (0.8%) .773
2014 2016 (99.3%) 14 (0.7%) .270
Abbreviations: BMI, body mass index; LMS, left main stem; MI, myocardial infarction; PCI, percutaneous coronary infection; SD, standard deviation.
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4 | DISCUSSION
This is the first and largest study to date to describe the predictors
and outcomes of perforation complicating ULMS-PCI using a large
national PCI registry. We found the incidence of perforation compli-
cating ULMS-PCI to be 0.9% which was stable over the study period
(Figure 1b/c). After adjusting for baseline and procedural variables,
independent predictors of perforation complicating ULMS-PCI were
female gender, number of stents used, rotational atherectomy, and
number of CTO attempted. Perforation in this context was indepen-
dently associated with peri-procedural complications as well as mor-
bidity and mortality at 30 days and 12 months.
Compared to reports on perforation complicating all-comer PCI,
the rates of perforation in ULMS-PCI were higher (0.9% vs. the
reported 0.4%).3 This likely reflects the complex/high risk nature of
patients requiring this procedure and is consistent with other studies
of patients with complex coronary anatomy, such as those undergoing
PCI with CTO disease where higher rates of perforation were
observed (1.4%).8 Indeed, we found that CTO is a complicating factor
and a predictor of perforation in ULMS-PCI, consistent with previous
studies.8 Despite the increase in the overall number of ULMS-PCI
over the study period, there was no significant change in the rate of
perforation. The observational nature of the study makes it difficult to
determine the reasons for this, but we suspect that improvement in
TABLE 2 Outcomes by coronary
perforation status in patients undergoing
LMS-PCI in England and Wales
2007–2014
Variable Odds ratio Lower CI Upper CI p value
Shock induced by procedure 14.884 6.540 33.873 <.001
DCCV 4.427 1.136 17.247 .032
Dissection 1.092 0.487 2.448 .830
Side-branch loss 13.172 5.846 29.677 <.001
Slow flow 1.781 0.387 8.202 .459
Arterial complication 1.211 0.247 5.944 .813
Transfusion 8.648 2.852 26.227 <.001
GI bleed 7.992 0.921 69.365 .059
In-hospital major bleed 30.019 15.158 59.450 <.001
Peri-procedural MI 9.019 3.380 19.025 <.001
Acute kidney injury 2.190 0.266 18.029 .466
In-hospital death 8.633 4.097 18.192 <.001
In-hospital MACCE 8.961 4.902 16.383 <.001
30-day mortality 5.301 2.741 10.251 <.001
12-month mortality 2.412 1.325 4.390 .004
Abbreviations: CI, confidence interval; LMS, left main stem; MACCE: major adverse cardiac and cerebrovascular
events; MI, myocardial infarction; PCI, percutaneous coronary infection.
F IGURE 2 Outcomes of coronary
perforation in patients undergoing
unprotected LMS-PCI and all PCI.3 Odds
ratio with 95% confidence intervals
demonstrating that outcomes of
perforation in ULMS-PCI are no worse
than all-comer PCI
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toolkit safety profile over the study period may have offset any
noticeable increase in the incidence of perforation.
In-hospital MACCE and mortality (30 days and 12 months) were
significantly more likely in ULMS-PCI complicated by perforation, infer-
ring a fivefold increased odds of death at 30 days (Table 2). These data
are a stark reminder that although perforation during ULMS-PCI is a
relatively rare event, when it does occur, there is an important associa-
tion with poor outcome. However, compared to previously published
studies on all-comer PCI complicated by perforation,3 the odds ratios
of in-hospital MACCE and mortality are comparable (Figure 2). This
suggests that although the rates of perforation in ULMS-PCI are just
over twice that in all-comer PCI, the outcomes are no worse and there-
fore should not detract from carrying out ULMS PCI when indicated.
The limited number of predictors associated with perforation
shown in Table S2 makes it difficult to anticipate its occurrence.
Indeed, in our study, with the exception of rotational atherectomy,
the occurrence of perforation does not seem to be significantly asso-
ciated with procedural variables (e.g., use of microcatheters, choice of
access, or antiplatelet agent). The association we observed with the
number of stents used may reflect the perforation treatment strategy
deployed by the operator. Consequently, operators need to recognize
this limitation of prediction and be prepared to tackle such complica-
tion arising by having the necessary tools, algorithms, and expertise
on board in order to reduce the rate of the adverse outcomes
described above (Table 2).
The complications that we have reported to be significantly asso-
ciated with perforation in ULMS-PCI are likely related to the occur-
rence of perforation (shock, tamponade, in-hospital major bleed)
and/or as a consequence of its treatment (shock, side-branch loss,
peri-procedural MI, DCCV, transfusion) and are consistent with previ-
ous reports.9,10 Indeed, the relatively recent advances in the treat-
ment of CP with covered stents are likely responsible for the higher
rates we have observed with major side branch loss and peri-
procedural shock seen in our study, both of which shown to be
strongly predictive of mortality.9,11
This analysis has several strengths. The BCIS data set includes
>98% of all PCI procedures performed in the United Kingdom, which,
therefore, reflects a national, real-world experience that includes
high-risk patients encountered in daily interventional practice (who
are often excluded from randomized controlled trials). Such large
national registry data with unselected enrolment are important for
evaluation of low-frequency complications, such as CP, particularly
given that such low event rates would mean that single-center regis-
tries or randomized controlled trials would be grossly underpowered.
4.1 | Limitations
The BCIS database does not differentiate between CPs resulting from
guide-wire and those perforations due to balloon or stent inflation or
indeed the anatomical location of such perforations. Second, the data-
base does not record guidewire data and therefore data on stiffness
or coating and the incidence of CP cannot be provided. Third, the
database does not record the Ellis classification of CP so that a sub-
stratification by perforation severity was not possible in this series.
Moreover, the BCIS database does not record the use of other treat-
ment strategies such covered stents, pericardial drains, or emboliza-
tion techniques and therefore data on outcomes with respect to
different therapies is not available. Furthermore, the follow-up period
is limited to 2014 as more recent data with reliable linkage to out-
comes are not available to the authors. Finally, because of the obser-
vational nature of this study, any conclusions may be influenced by
unmeasured confounders, such as frailty or anatomical considerations.
5 | CONCLUSIONS
CP is an infrequent event during ULMS-PCI with very few predictors
and a steady incidence over the study period of 7 years. It is associ-
ated with significantly adverse peri-procedural outcomes as well as
increased morbidity and mortality. However, the likelihood of occur-
rence of these outcomes is similar to previous studies that examined
perforation in all-comer PCI and therefore should not be a basis for
avoiding indicated ULMS-PCI.
CONFLICT OF INTEREST
The authors declare no potential conflict of interest.
ORCID




1. Rampat R, Hildick-Smith D. Left main stem percutaneous coronary
intervention - data and ongoing trials. Interv Cardiol. 2015;10:
132-135.
2. Kindi HA, Samaan A, Hosny H. NOBLE and EXCEL: the debate for
excellence in dealing with left main stenosis. Glob Cardiol Sci Pract.
2018;2018:3.
3. Kinnaird T, Kwok CS, Kontopantelis E, et al. Incidence, determinants,
and outcomes of coronary perforation during percutaneous coronary
intervention in the United Kingdom between 2006 and 2013: an anal-
ysis of 527 121 cases from the British cardiovascular intervention
society database. Circ Cardiovasc Interv. 2016;9(8):e003449. https://
doi.org/10.1161/CIRCINTERVENTIONS.115.003449.
4. Alaour B, Onwordi E, Khan A, Dana A. Clinical outcome of left Main
stem (LMS) percutaneous coronary intervention (PCI) in a large non-
surgical UKCenter: a 5-year clinical experience. J Am Coll Cardiol Intv.
2018;11(4):S16-S17.
5. Kinnaird T, Calvert P, Anderson R, et al. Coronary perforation compli-
cating percutaneous coronary intervention in patients presenting with
an acute coronary syndrome: an analysis of 1,013 perforation cases
from the British cardiovascular intervention society database. J Am
Coll Cardiol. 2018;72(299):37–42.
6. British Cardiovascular Intervention Society. BCIS Audit Returns for
Adult Interventional Procedures Jan 2015-Dec 2015.
7. Ludman PF, British Cardiovascular Intervention S. British cardiovascu-
lar intervention society registry for audit and quality assessment of
percutaneous coronary interventions in the United Kingdom. Heart.
2011;97:1293-1297.
6 HUSSAIN ET AL.
8. Kinnaird T, Anderson R, Ossei-Gerning N, et al. Legacy effect of coronary
perforation complicating percutaneous coronary intervention for chronic
total occlusive disease: an analysis of 26 807 cases from the British cardio-
vascular intervention society database. Circ Cardiovasc Interv. 2017;10(5):
e004642. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004642.
9. Nguyen-Trong PK, Rangan BV, Karatasakis A, et al. Predictors and
outcomes of side-branch occlusion in coronary chronic total occlusion
interventions. J Invasive Cardiol. 2016;28:168-173.
10. Gorenek B, Lundqvist CB, Terradellas JB, et al. Cardiac arrhythmias in
acute coronary syndromes: position paper from the joint EHRA,
ACCA, and EAPCI task force. Eur Heart J Acute Cardiovasc Care.
2015;4:386.
11. Wisniewska-Szmyt J, Kubica J, Sukiennik A, et al. One-year outcomes
of left main coronary artery stenting in patients with cardiogenic
shock. Cardiol J. 2007;14:67-75.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Hussain HI, Protty MB, Gallagher S,
et al. The impact of coronary perforation in percutaneous
interventions involving the left main stem coronary artery in
the United Kingdom 2007–2014: Insights from the British
Cardiovascular Intervention Society database. Catheter
Cardiovasc Interv. 2020;1–7. https://doi.org/10.1002/ccd.
28933
HUSSAIN ET AL. 7
